Nonprescription Medication Use in Hospice Patients

Abstract

Objective: Patients admitted to hospice are more vulnerable to age-related physiologic changes, polypharmacy, and inappropriate medication use and monitoring. The objective of this study was to characterize the utilization of nonprescription medications in a hospice population. Methods: This was a retrospective study designed to characterize nonprescription or over-the-counter medication use in hospice patients. Data for this study were provided by Seasons Hospice & Palliative Care, a national hospice organization with licenses to operate in 19 states and collected from January 1 to December 31, 2016. The most frequently utilized nonprescription medications, therapeutic classes, and the frequency of patients with at least 1 claim within a therapeutic class were summarized. Results: The final study population included 62 639 orders representing 15 164 patients. The average age was 79.31 years with a standard deviation of 13.31 years. The average length of stay was 26.80 days with a standard deviation of 44.14 days. The top 5 most common medications were as follows: acetaminophen (25.15%), bisacodyl (21.69%), senna (8.35%), omeprazole (4.51%), and docusate (4.46%). Approximately 13 714 (29.67%) of patients were exposed to analgesics, 13 469 (29.14%) to laxatives, and 3535 (7.65%) to antacids or antigas medications. Conclusion: This study highlights numerous opportunities for improvement in the use of nonprescription medications among hospice patients. Reducing the use of nonprescription medications that are ineffective or produce unwanted side effects can contribute to improving the quality of care that patients receive.

Cross-sectional study to evaluate patients’ medication management with a new model of care: incorporating a pharmacist into a community specialist palliative care telehealth service

“…However, despite patients’ home being the most ideal setting for palliative care, pharmacists’ involvement in the palliative care team is not reflected in the community setting [ 11 ]. Patients with life-limiting diseases are often on complex medication regimes including prescribed, over the counter (OTC) and complementary and alternative medication (CAM) [ 12 , 13 ] to manage symptoms, and other chronic comorbidities [ 14 ]. These patients are at high risk of medicine-related problems (MRPs) and often benefit from comprehensive medication reviews [ 15 ].…”